학술논문
Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–BioNTech) COVID‐19 vaccine.
Document Type
Article
Author
Source
Subject
*BOOSTER vaccines
*PITYRIASIS rubra
*COVID-19 vaccines
*URTICARIA
*MESSENGER RNA
*ORAL vaccines
*
*
*
*
*
Language
ISSN
1396-0296
Abstract
However, data on cutaneous reactions following booster dose of COVID-19 vaccines are still limited.1,2 Herein, we present a case of pityriasis rubra pilaris (PRP) following a booster dose of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine. Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine Data on various cutaneous adverse events as a result of widespread SARS-CoV-2 vaccination is currently accumulating. [Extracted from the article]